MangoRx faces Eli Lilly lawsuit over alleged copying of weight-loss drugs Zepbound/Mounjaro

MANGOCEUTICALS, INC.

Eli Lilly filed a lawsuit claiming MangoRx improperly copied its weight-loss medicines Zepbound and Mounjaro.
MangoRx strongly refutes all claims regarding the sale of compounded tirzepatide and will vigorously defend.
MangoRx provides access to compounded tirzepatide via its telemedicine platform for men's health and wellness.
No financial details or specific damages claimed are disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.